Alternaria alternata soft tissue infection in a forearm transplant recipient

Surgical Infections

Volumn 8, Issue 5, 2007, Pages 539-544

  Bonatti, Hugo ^a,c   Lass Flörl, Cornelia ^a   Zelger, Bettina ^b   Lottersberger, Clemens ^a   Singh, Nina ^d   Pruett, Timothy L ^c   Margreiter, Raimund ^a   Schneeberger, Stefan ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B LIPID COMPLEX; CIDOFOVIR; GANCICLOVIR; ITRACONAZOLE; PREDNISOLONE; TACROLIMUS;

ABSENCE OF SIDE EFFECTS; ADULT; ALTERNARIA ALTERNATA; ARTICLE; CASE REPORT; DRUG DOSE REDUCTION; FOLLOW UP; FOREARM; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MICROSCOPY; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; NONHUMAN; ORGAN TRANSPLANTATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; SOFT TISSUE INFECTION;

ADULT; ALTERNARIA; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ARM; DRUG THERAPY, COMBINATION; FOREARM; HUMANS; ITRACONAZOLE; MALE; MYCOSES; TRANSPLANTATION; WOUND INFECTION; WOUNDS, PENETRATING;

EID: 36148951010     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2006.095     Document Type: Article

References (51)

1. Saalwachter AR, Hedrick T, Sawyer RG. The other fungi: It's not just Candida albicans any more. Surg Infect 2006;7:143-150.
2. Lechler RI, Sykes M, Thomson AW, et al. Organ transplantation: How much of the promise has been realized? Nat Med 2005;11:605-613.
3. Lanzetta M, Petruzzo P, Margreiter R, et al. The International Registry on Hand and Composite Tissue Transplantation. Transplantation 2005;79:1210-1214.
4. Groll AH, Walsh TJ. Uncommon opportunistic fungi: New nosocomial threats. Clin Microbiol Infect 2001;7(Suppl 2):8-24.
5. Wheat LJ, Goldman M, Sarosi G. State-of-the-art review of pulmonary fungal infections. Semin Respir Infect 2002;17:158-181.
6. Miele PS, Levy CS, Smith MA, et al. Primary cutaneous fungal infections in solid organ transplantation: A case series. Am J Transplant 2002;2:678-683.
7. Gilaberte M, Bartralot R, Torres JM, et al. Cutaneous alternariosis in transplant recipients: Clinicopathologic review of 9 cases. J Am Acad Dermatol 2005;52:653-659.
8. Pereiro M Jr, Pereiro Ferreiros MM, De Hoog GS, et al. Cutaneous infection caused by Alternaria in patients receiving tacrolimus. Med Mycol 2004;42:277-282.
9. Jo WK, Seo YJ. Indoor and outdoor bioaerosol levels at recreation facilities, elementary schools, and homes. Chemosphere June 24, 2005.
10. Peternel R, Culig J, Hrga I. Atmospheric concentrations of Cladosporium spp. and Alternaria spp. spores in Zagreb (Croatia) and effects of some meteorological factors. Ann Agric Environ Med 2004;11:303-307.
11. Tournas VH. Spoilage of vegetable crops by bacteria and fungi and related health hazards. Crit Rev Microbiol 2005;31:33-44.
12. Cantani A, Ciaschi V. Epidemiology of Alternaria alternata allergy: A prospective study in 6840 Italian asthmatic children. Eur Rev Med Pharmacol Sci 2004;8:289-294.
13. Romano C, Paccagnini E, Difonzo EM. Onychomycosis caused by Alternaria spp. in Tuscany, Italy from 1985 to 1999. Mycoses 2001;44:73-76.
14. Ioannidou DJ, Stefanidou MP, Maraki SG, et al. Cutaneous alternariosis in a patient with idiopathic pulmonary fibrosis. Int J Dermatol 2000;39:293-295.
15. Benito N, Moreno A, Puig J, et al. Alternariosis after liver transplantation. Transplantation 2001;72:1840-1843.
16. Lo Cascio G, Ligozzi M, Maccacaro L, et al. Utility of molecular identification in opportunistic mycotic infections: A case of cutaneous Alternaria infectoria infection in a cardiac transplant recipient. J Clin Microbiol 2004;42:5334-5336.
17. Gilmour TK, Rytina E, O'Connell PB, et al. Cutaneous alternariosis in a cardiac transplant recipient. Australas J Dermatol 2001;42:46-49.
18. Kazory A, Ducloux D, Reboux G, et al. Cutaneous Alternaria infection in renal transplant recipients: A report of two cases with an unusual mode of transmission. Transplant Infect Dis 2004;6:46-49.
19. Baykal C, Kazancioglu R, Buyukbabani N, et al. Simultaneous cutaneous and ungual alternariosis in a renal transplant recipient. Br J Dermatol 2000;143:910-912.
20. Magina S, Lisboa C, Santos P, et al. Cutaneous alternariosis by Alternaria chartarum in a renal transplanted patient. Br J Dermatol 2000;142:1261-1262.
21. Garcia-Diaz JB, Baumgarten K. Phaeohyphomycotic infections in solid organ transplant patients. Semin Respir Infect 2002;17:303-309.
22. Perfect JR. Use of newer antifungal therapies in clinical practice: What do the data tell us? Oncology 2004;18(13 Suppl 7):15-23.
23. Golan Y. Overview of transplant mycology. Am J Health Syst Pharm 2005;62(8 Suppl 1):S17-S21.
24. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003;37:221-229.
25. Schneeberger S, Kreczy A, Brandacher G, et al. Steroid- and ATG-resistant rejection after double forearm transplantation responds to Campath-1H. Am J Transplant 2004;4:1372-1374.
26. Schneeberger S, Lucchina S, Lanzetta M, et al. Cytomegalovirus-related complications in human hand transplantation. Transplantation 2005;80:441-447.
27. Bonatti H, Aigner F, De Clercq E, et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transplant Int (in press).
28. Halaby T, Boots H, Vermeulen A, et al. Phaeohyphomycosis caused by Alternaria infectoria in a renal transplant recipient. J Clin Microbiol 2001;39:1952-1955.
29. Kim JO, Kim GH, Kim BC, et al. Cutaneous alternariosis in a renal transplant recipient. Int J Dermatol 2003;42:630-631.
30. Villacian JS, Paya CV. Prevention of infections in solid organ transplant recipients. Transplant Infect Dis 1999;1:50-64.
31. Brady RC, Sommerkamp TG. Thorn-induced Alternaria flexor tenosynovitis of the hand. Pediatr Infect Dis J 2001;20:1097-1098.
32. Ferrer C, Munoz G, Alio JL, et al. Polymerase chain reaction diagnosis in fungal keratitis caused by Alternaria alternata. Am J Ophthalmol 2002;133:398-399.
33. de Hoog GS, Horre R. Molecular taxonomy of the Alternaria and Ulocladium species from humans and their identification in the routine laboratory. Mycoses 2002;45:259-276.
34. Merino E, Banuls J, Boix V, et al. Relapsing cutaneous alternariosis in a kidney transplant recipient cured with liposomal amphotericin B. Eur J Clin Microbiol Infect Dis 2003;22:51-53.
35. Pereiro M Jr, Suarez I, Monteagudo B, et al. Alternariosis refractory to itraconazole in a patient suffering from bullous pemphigoid. Dermatology 2001;202:268-270.
36. Lyke KE, Miller NS, Towne L, et al. A case of cutaneous ulcerative alternariosis: Rare association with diabetes mellitus and unusual failure of itraconazole treatment. Clin Infect Dis 2001;32:1178-1187.
37. Machet L, Machet MC, Vaillant L. Effectiveness of terbinafine in cutaneous alternariosis. Br J Dermatol 2000;143:1115-1116.
38. Radford SA, Johnson LM, Warnock DW. In vitro studies of activity of voriconazole (UK-109,496), a new trizole antifungal agent, against emerging and less-common mold pathogens. Antimicrob Ag Chemother 1997;41:841-843.
39. Espinel-Ingroff A. Comparison of in vitro activities of ner triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts. J Clin Microbiol 1998;36:2950-2956.
40. Pfaller MA, Messer SA, Hollis RJ, et al. Antifungal activities of posaconazole, favuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000. Antimicrob Agents Chemother 2002;46:1032-1037.
41. Sabatelli F, Patel R, Mann PA, et al. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts. Antimicrob Agents Chemother 2006;50:2009-2015.
42. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002;21:240-248.
43. Nucci M. Related emerging moulds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003;16:607-612.
44. Cooke FJ, Terpos E, Boyle J, et al. Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin. Clin Microbiol Infect 2003;9:1238-1241.
45. Chakrabarti A, Gupta V, Biswas G, et al. Primary cutaneous aspergillosis: Our experience in 10 years. J Infect 1998;37:24-27.
46. Larche J, Machouart M, Burton K, et al. Diagnosis of cutaneous mucormycosis due to Rhizopus microsporus by an innovative PCR-restriction fragment-length polymorphism method. Clin Infect Dis 2005;41:1362-1365.
47. Padmaja IJ, Ramani TV, Kalyani S. Cutaneous zygomycosis: Necrotising fascitis due to Saksenaea vasiformis. Indian J Med Microbiol 2006;24(1):58-60.
48. Cocuroccia B, Gaido J, Gubinelli E, et al. Localized cutaneous hyalohyphomycosis caused by a Fusarium species infection in a renal transplant patient. J Clin Microbiol 2003;41:905-907.
49. Lim D, Lee YS, Chang AR. Rapid diagnosis of Penicillium marneffei infection by fine needle aspiration cytology. J Clin Pathol 2006;59:443-444.
50. Jayamohan Y, Ribes JA. Pseudallescheriasis: A summary of patients from 1980-2003 in a tertiary care center. Arch Pathol Lab Med 2006;130:1843-1846.
51. Gullberg RM, Quintanilla A, Levin ML, et al. Sporotrichosis: Recurrent cutaneous, articular, and central nervous system infection in a renal transplant recipient. Rev Infect Dis 1987;9:369-375.